,,iii  #aad? ,,congress  #a/ ,session   
,s4 ,,res4 #bcc  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,july #bh1 #bjae ,ms4 
,hirono 7= h]self1 ,mr4 ,s*um]1 & ,mr4  
,s*atz7 submitt$ ! foll[+ resolution2   
:i* 0 ref]r$ to ! ,committee on ,heal?1 
,education1 ,labor1 & ,p5sions          
,,resolution  ,recogniz+ ,july #bh1     
#bjae1 z ,_w ,hepatitis ,day4  ,:]eas   
hepatitis ,b & hepatitis ,c1 & !        
incid5ce ( liv] disease caus$ by ^!     
viruses1 h become urg5t problems ( a    
global proportion2 ,:]eas an e/imat$    
#cej1jjj1jjj p worldwide live ) *ronic  
hepatitis ,b1 & an e/imat$ #ghj1jjj p   
worldwide die ea* ye> due to hepatitis  
,b2 ,:]eas an e/imat$ #aej1jjj1jjj p    
worldwide are *ronically infect$ )      
hepatitis ,c1 & an e/imat$ #ejj1jjj p   
worldwide die ea* ye> due to a          
liv]-relat$ illness caus$ by hepatitis  
,c2 ,:]eas an e/imat$ #a1jjj1jjj p      
worldwide die ea* ye> due to liv]       
failure or prim>y liv] canc] result+ f a
 *ronic infection ( hepatitis2 ,:]eas an

 e/imat$ #e1cjj1jjj p 9 ! ,unit$ ,/ates 
are infect$ ) ei!r hepatitis ,b or      
hepatitis ,c1 includ+ #a1djj1jjj p :o   
are *ronically infect$ ) hepatitis ,b & 
#b1gjj1jjj p :o are *ronically infect$ )
 hepatitis ,c2 ,:]eas ! ,c5t]s =        
,disease ,control & ,prev5tion 7ref]r$  
to 9 ?is preamble z ,,cdc7 e/imat$ t !re
 7 #ai1gfd new hepatitis ,b infections &
 #bi1gah new hepatitis ,c infections1   
respectively1 9 ! ,unit$ ,/ates 9 #bjac2
 ,:]eas ! ,,cdc has f\nd significant    
increases 9 ! transmission ( new        
hepatitis cases 9 ! ,unit$ ,/ates s9ce  
#bjaj1 includ+ a #aea p]c5t increase    
betwe5 #bjaj & #bjac 9 new transmissions
 ( hepatitis ,c 9 ! ,unit$ ,/ates2      
,:]eas *ronic viral hepatitis claims    
?\s&s ( lives ea* ye> 9 ! ,unit$ ,/ates1
 ) #ai1cfh dea?s due to hepatitis ,c 9 !
 ,unit$ ,/ates 9 #bjac2 ,:]eas1 9 #bjad1
 #d1ejj1jjj1jjj 9 ,m$ic>e funds 7 sp5t  
on hepatitis ,c treatm5ts2 ,:]eas a     
p]son :o has become *ronically infect$ )
 hepatitis ,b or hepatitis ,c may n h   

symptoms = up to #dj ye>s aft] ! initial
 infection occurr$2 ,:]eas              
,african-,am]icans1 ,asian ,am]icans1   
,pacific ,isl&]s1 ,lat9os1 ,native      
,am]icans1 ,alaska ,natives1 gay &      
bisexual m51 & p]sons :o inject drugs   
intrav5\sly all h high] rates ( *ronic  
viral hepatitis infections 9 ! ,unit$   
,/ates ?an o!r gr\ps ( p2 ,:]eas ,asian 
,am]icans & ,pacific ,isl&]s be> !      
greate/ burd5 ( hepatitis ,b relat$     
dea?s 9 ! ,unit$ ,/ates2 ,:]eas         
hepatitis ,c is #aj times m infecti\s   
?an human immunodefici5cy virus 7ref]r$ 
to 9 ?is preamble z ,,hiv72 ,:]eas      
hepatitis ,b is #ej to #ajj times m     
infecti\s ?an ,,hiv2 ,:]eas an e/imat$  
#be p]c5t ( p :o live 9 ! ,unit$ ,/ates 
& are infect$ ) ,,hiv are also infect$ )
 hepatitis ,c2 ,:]eas life expectancies 
= p]sons infect$ ) ,,hiv h increas$ )   
antiretroviral treatm5t1 & liv] disease1
 mu* ( :i* is relat$ to hepatitis ,b &  
hepatitis ,c infections1 has become !   
mo/ common cause ( dea? among ?is       

population t is n relat$ to acquir$     
immune defici5cy syndrome2 ,:]eas1      
despite ! fact t *ronic viral hepatitis 
is ! mo/ common blood-borne infection 9 
! ,unit$ ,/ates1 #fe p]c5t ( p liv+ )   
hepatitis ,b & an e/imat$ #ge p]c5t ( p 
liv+ ) hepatitis ,c are unaw>e ( _!     
infection2 ,:]eas hepatitis ,b is       
prev5table ?r\gh vacc9ation1 & bo?      
hepatitis ,b & hepatitis ,c are         
prev5table ) prop] public heal?         
int]v5tions1 includ+ programs t (f]     
access to /]ile injection equipm5t = p  
:o inject drugs intrav5\sly2 ,:]eas     
effective & safe treatm5t is available =
 p liv+ ) hepatitis ,b & hepatitis ,c1  
includ+ new curative treatm5ts =        
hepatitis ,c2 & ,:]eas ! goals ( ,_w    
,hepatitis ,day on ,july #bh1 #bjae1 are
 to-- 7#a7 highlight ! global nature (  
*ronic viral hepatitis epidemics2  7#b7 
recognize t hepatitis c be prev5t$ &    
elim9at$ 9 "p ?r\gh a compreh5sive      
public education & aw>5ess campaign     
design$ to id5tify ^? at risk =1 & liv+ 

)1 hepatitis2  7#c7 in=m pati5ts ab\t   
new treatm5ts t are available =         
hepatitis2 &  7#d7 help increase ! l5g? 
& quality ( life = p diagnos$ ) *ronic  
hepatitis ,b & hepatitis ,c infections3 
,n[1 !re=e1 be x  ,t ! ,s5ate-- 7#a7    
recognizes ,july #bh1 #bjae1 z ,_w      
,hepatitis ,day2  7#b7 supports broad   
access to hepatitis ,b & hepatitis ,c   
treatm5ts2  7#c7 supports rais+ aw>5ess 
( ! risks & consequ5ces ( undiagnos$    
*ronic hepatitis ,b & hepatitis ,c      
infections2 &  7#d7 calls = a robu/     
gov]nm5tal & public heal? response to   
protect ! heal? ( ! approximately       
#e1jjj1jjj p 9 ! ,unit$ ,/ates &        
#djj1jjj1jjj p worldwide :o suff] f     
*ronic viral hepatitis4